Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation

Joseph Maleszewski, Melanie C. Bois, John P. Bois, Philip M. Young, John M. Stulak, Kyle W. Klarich

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).

Original languageEnglish (US)
Pages (from-to)202-227
Number of pages26
JournalJournal of the American College of Cardiology
Volume72
Issue number2
DOIs
StatePublished - Jul 10 2018

Fingerprint

Heart Neoplasms
Carcinoid Tumor
Amyloidosis
Neoplasms
Cardiovascular Diseases
Cardiotoxicity

Keywords

  • masses
  • neoplasms
  • tumors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Neoplasia and the Heart : Pathological Review of Effects With Clinical and Radiological Correlation. / Maleszewski, Joseph; Bois, Melanie C.; Bois, John P.; Young, Philip M.; Stulak, John M.; Klarich, Kyle W.

In: Journal of the American College of Cardiology, Vol. 72, No. 2, 10.07.2018, p. 202-227.

Research output: Contribution to journalReview article

Maleszewski, Joseph ; Bois, Melanie C. ; Bois, John P. ; Young, Philip M. ; Stulak, John M. ; Klarich, Kyle W. / Neoplasia and the Heart : Pathological Review of Effects With Clinical and Radiological Correlation. In: Journal of the American College of Cardiology. 2018 ; Vol. 72, No. 2. pp. 202-227.
@article{9c1e6afbba6b47d58ad68917808c5bf3,
title = "Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation",
abstract = "The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).",
keywords = "masses, neoplasms, tumors",
author = "Joseph Maleszewski and Bois, {Melanie C.} and Bois, {John P.} and Young, {Philip M.} and Stulak, {John M.} and Klarich, {Kyle W.}",
year = "2018",
month = "7",
day = "10",
doi = "10.1016/j.jacc.2018.05.026",
language = "English (US)",
volume = "72",
pages = "202--227",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Neoplasia and the Heart

T2 - Pathological Review of Effects With Clinical and Radiological Correlation

AU - Maleszewski, Joseph

AU - Bois, Melanie C.

AU - Bois, John P.

AU - Young, Philip M.

AU - Stulak, John M.

AU - Klarich, Kyle W.

PY - 2018/7/10

Y1 - 2018/7/10

N2 - The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).

AB - The intersection of oncological and cardiovascular diseases is an increasingly recognized phenomenon. This recognition has led to the emergence of cardio-oncology as a true subspecialty. This field is not simply limited to primary cardiac tumors or complications of chemotherapeutic medications. Rather, it also encompasses metastatic cardiovascular complications and secondary cardiovascular effects of the underlying neoplasia. This review will broadly cover primary and metastatic cardiac neoplasms, as well as secondary cardiovascular effects of extracardiac neoplasia (e.g., amyloidosis, carcinoid valvulopathy, and chemotherapeutic cardiotoxicities).

KW - masses

KW - neoplasms

KW - tumors

UR - http://www.scopus.com/inward/record.url?scp=85049018045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049018045&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.05.026

DO - 10.1016/j.jacc.2018.05.026

M3 - Review article

C2 - 29976295

AN - SCOPUS:85049018045

VL - 72

SP - 202

EP - 227

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 2

ER -